Top Markets
Coin of the day
Pharma Mar, S.A. Pharma Mar, S.A.

Pharma Mar, S.A.

PHM
주식 순위 #7110
Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and... Pharma Mar, S.A., a biopharmaceutical firm established in 1986 and headquartered in Madrid, Spain, is dedicated to the research, development, production, and global sale of marine-derived bioactive compounds. Its primary focus is oncology, with operations spanning Spain, Italy, Germany, Ireland, the wider European Union, the United States, and other international markets. The company's activities are organized into three key segments: Oncology, Diagnostics, and RNA interference. Among its developed and commercialized treatments are Yondelis, prescribed for soft tissue sarcomas and ovarian cancer; Aplidin, targeting multiple myeloma; and Zepzelca, used for patients with small cell lung cancer. Furthermore, Pharma Mar is advancing PM14, currently in Phase II clinical trials for various solid tumors. Beyond pharmaceuticals, the company manufactures and markets diagnostic kits and is involved in creating therapeutic drugs designed to reduce or silence gene expression.
주가
$99.16
마지막 동기화: 2026-08-27
시가총액
$1.72B
변동 (1일)
0.00%
변동 (1년)
2.52%
국가
ES
거래 Pharma Mar, S.A. (PHM)

카테고리

Pharma Mar, S.A. (PHM)의 주가 이력
최고 종가: $97.96 (2026-08-01 기준)

최저 종가: $218.83 (2000-09-01 기준)
Pharma Mar, S.A.의 주가 이력 (2000 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 11.19%
2025 7.04%
2024 82.98%
2023 -37.27%
2022 15.74%
2021 -33.18%
2020 155.86%
2019 122.05%
2018 -52.82%
2017 5.76%
2016 -18.80%
2015 -2.25%
2014 5.71%
2013 96.55%
2012 -18.58%
2011 -45.75%
2010 -36.04%
2009 20.26%
2008 -51.99%
2007 35.46%
2006 3.21%
2005 0.67%
2004 7.60%
2003 2.35%
2002 -18.68%
2001 -49.94%
2000 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.53 -12.48%
AU
$140.81 475.44%
US
$765.25 7.74%
CH